- Home
- BBIO vs PS Comparison
BBIO vs PS Comparison
Compare BBIO & PS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$85.26
Company Overview
Basic Information| Metric | BBIO | PS |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.9B | 14.1B |
| IPO Year | 2019 | 2026 |
Fundamental Metrics
Financial Performance| Metric | BBIO | PS |
|---|---|---|
| Price | $85.26 | $33.74 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 25 | 0 |
| Target Price | ★ $86.33 | N/A |
| AVG Volume (30 Days) | ★ 3.3M | 139.7K |
| Earning Date | 05-12-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $502,076,000.00 | N/A |
| Revenue This Year | $89.45 | N/A |
| Revenue Next Year | $73.78 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 126.26 | N/A |
| 52 Week Low | $42.09 | $29.38 |
| 52 Week High | $93.42 | $37.31 |
Technical Indicators
Market Signals| Indicator | BBIO | PS |
|---|---|---|
| Relative Strength Index (RSI) | 66.40 | 47.41 |
| Support Level | $62.93 | $32.76 |
| Resistance Level | $93.42 | $35.82 |
| Average True Range (ATR) | 3.35 | 2.05 |
| MACD | -0.14 | -0.15 |
| Stochastic Oscillator | 42.05 | 21.23 |
Price Performance
Historical Comparison BBIO
PS
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.